insights_auto
Why is BOT down 11.11%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.0080
arrow_downward
-11.11%(-0.00100) 1D
Nov 16, 4:10:15 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
19.89M
Avg. vol.
9.99M
Volume
30.19M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
19.89M
Avg. vol.
9.99M
Volume
30.19M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
News stories
From web sources and news partners
MarketWatch
·
20 minutes ago
These 13 S&P 500 stocks can rise up to 70% over the next year, according to analysts
Coinpaper
·
1 hour ago
Stock Market Today: S&P 500 and Nasdaq Fall as Nvidia Selloff Deepens
Traders Union
·
31 minutes ago
Peter Tuchman: S&P 500 loses over $800 billion in market cap
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebotanixpharma.com